Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
11/19/1998 | WO1998051706A1 Tumor-associated antigen |
11/19/1998 | WO1998051705A1 Peptides with antiviral activity |
11/19/1998 | WO1998051704A1 PEPTIDES PROMOTING THE ACTIVATION OF LATENT TGF-β AND METHOD FOR SCREENING TGF-β ACTIVITY REGULATORS |
11/19/1998 | WO1998051701A1 Tumor surface protein and its complementary surface receptor on naive natural killer cells |
11/19/1998 | WO1998051697A2 Method for producing polymers having nucleo-bases as side-groups |
11/19/1998 | WO1998051351A1 Therapeutic and diagnostic tools for impaired glucose tolerance conditions |
11/19/1998 | WO1998051350A1 Methods of treatment using nbs-1, antibodies and proteins thereto, and uses of the antibodies |
11/19/1998 | WO1998051340A1 Fas ligand expressing antigen presenting cells for tolerance induction |
11/19/1998 | WO1998051337A2 Immunogenic compositions to the cck-b/gastrin-receptor and methods for the treatment of tumors |
11/19/1998 | WO1998051336A1 Targeted delivery to t lymphocytes |
11/19/1998 | WO1998051329A1 Cachexia remedy |
11/19/1998 | WO1998051328A1 Stabilisation of interferons in aqueous solution for manufacture of sublingually administered tablets |
11/19/1998 | WO1998051327A1 Therapeutic agent, treatment method, prophylactic agent, and prophylactic method for canine and feline immunological diseases |
11/19/1998 | WO1998051325A2 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods |
11/19/1998 | WO1998051324A1 Peptide parathyroid hormone analogs |
11/19/1998 | WO1998051323A1 Novel antiangiogenic peptide agents and their therapeutic and diagnostic use |
11/19/1998 | WO1998051322A1 CONOPEPTIDES AuIA, AuIB AND AuIC |
11/19/1998 | WO1998051321A1 Tissue factor for influencing blood vessel formation |
11/19/1998 | WO1998051295A1 Hiv-1 protease inhibitors, process for producing the same, and medicinal compositions |
11/19/1998 | WO1998040483A3 28 human secreted proteins |
11/19/1998 | WO1998037180A3 Hcv fusion protease and polynucleotide encoding same |
11/19/1998 | WO1998037095A3 Recombinant pox virus for immunization against muc1 tumor-associated antigen |
11/19/1998 | WO1998037089A3 Matrix derived anti-hiv peptides and transdominant proteins |
11/19/1998 | WO1998035694A3 A pharmaceutical composition for treating hepatitis b virus (hbv) infection |
11/19/1998 | WO1998035550A3 Insect ecdysteroid receptors |
11/19/1998 | WO1998035061A3 Member of the tnf family useful for treatment and diagnosis of disease |
11/19/1998 | WO1998035014A3 Probiotic strains from lactobacillus salivarius and antimicrobial agents obtained therefrom |
11/19/1998 | WO1998034640A3 Synthetic hiv gag genes |
11/19/1998 | WO1998033929A3 Use of a polypeptide as cell receptor for adenoviruses |
11/19/1998 | WO1998033896A3 Microorganisms with increased production of clavulanic acid |
11/19/1998 | WO1998031810A3 Mammalian chemokines; receptors; reagents; uses |
11/19/1998 | WO1998031802A3 Secreted proteins and polynucleotides encoding them |
11/19/1998 | WO1998026061A3 Expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease |
11/19/1998 | WO1998026051A3 Tryparedoxin, expression plasmid, process of production, use, test system and pharmaceutical preparation |
11/19/1998 | DE3845000C2 Compsn. contg. somatostatin analogues for treating breast cancer |
11/19/1998 | DE19720914A1 Verfahren zum Nachweis von HIV-Antikörpern und dazu verwendete Antigene A method for the detection of HIV antibodies and antigens used for this purpose |
11/19/1998 | DE19720216A1 New isonitrile compounds |
11/19/1998 | CA2290781A1 Antimicrobial peptide |
11/19/1998 | CA2290756A1 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods |
11/19/1998 | CA2290755A1 The use of a bone morphogenetic protein (bmp) receptor complex for screening |
11/19/1998 | CA2290477A1 Polynucleotides encoding a cd53-like transmembrane protein |
11/19/1998 | CA2290443A1 Peptide parathyroid hormone analogs |
11/19/1998 | CA2290071A1 Peptides which enhance transport of an active agent across tissues and compositions and methods of using the same |
11/19/1998 | CA2290039A1 Transgenic animal expressing non-native wild-type and familial alzheimer's disease mutant presenilin 1 protein on native presenilin 1 null background |
11/19/1998 | CA2289960A1 Peptides having a cyclic structure and restoring the activities of p53 protein to mutant p53 protein |
11/19/1998 | CA2289953A1 Methods for producing retroviral vectors with an altered tropism |
11/19/1998 | CA2289910A1 Therapeutic agent for cachexia |
11/19/1998 | CA2289751A1 Gene encoding for systemic acquired resistance in arabidopsis |
11/19/1998 | CA2289720A1 Hgf polypeptides and their use in therapy |
11/19/1998 | CA2289117A1 Method and construct for inhibition of cell migration |
11/19/1998 | CA2288599A1 Tumor-associated antigen |
11/19/1998 | CA2288456A1 Method for increasing yields or recombinant proteins |
11/19/1998 | CA2288328A1 Lentivirus-based gene transfer vectors |
11/19/1998 | CA2288218A1 Novel differentiation-inhibitor |
11/19/1998 | CA2288117A1 Tissue factor for influencing blood vessel formation |
11/19/1998 | CA2287911A1 Apo-2 receptor |
11/19/1998 | CA2287839A1 Therapeutic and diagnostic tools for impaired glucose tolerance conditions |
11/19/1998 | CA2259956A1 Peptides promoting the activation of latent tgf-.beta. and method for screening tgf-.beta. activity regulators |
11/19/1998 | CA2259425A1 Hiv-1 protease inhibitors, process for producing the same, and medicinal compositions |
11/19/1998 | CA2221866A1 A novel member of the il-1 family, il-1 delta |
11/18/1998 | EP0878867A2 Connector used for flexible flat cable |
11/18/1998 | EP0878714A1 Conservation of aeguorin reagents |
11/18/1998 | EP0878551A2 Enhancement of the factor-VII sensitivity of a thromboplastin reagent |
11/18/1998 | EP0878547A1 Methods for producing retroviruses with an altered tropism |
11/18/1998 | EP0878546A1 A gene delivery vehicle expressing the apoptosis-inducing proteins VP2 and/or apoptin |
11/18/1998 | EP0878545A2 OSP a protein of borrelia burgdorferi subgroups, encoding genes and vaccines |
11/18/1998 | EP0878544A1 Epididymis specific DNA sequences and their use |
11/18/1998 | EP0878543A1 cDNA FRAGMENTS OF GENE CAUSATIVE OF SPINOCEREBELLAR ATAXIA TYPE 2 |
11/18/1998 | EP0878542A2 cDNA clone HMTMF81 that encodes a novel human 7-transmembrane receptor |
11/18/1998 | EP0878479A2 G-protein coupled receptor (HOFNH30) |
11/18/1998 | EP0877943A1 Methods for measurement and treatment predicated on the presence of advanced glycosylation endproducts in tobacco and its combustion byproducts |
11/18/1998 | EP0877820A1 Diagnostic test to determine the malignancy of smooth muscle tumors |
11/18/1998 | EP0877819A1 Disruption of expression of multiple alleles of mammalian genes |
11/18/1998 | EP0877816A1 Expression of group b neisseria meningitidis outer membrane (mb3) protein from yeast and vaccines |
11/18/1998 | EP0877814A1 Raspberry promoters for expression of transgenes in plants |
11/18/1998 | EP0877813A1 Plant tissue/stage specific promoters for regulated expression of transgenes in plants |
11/18/1998 | EP0877812A1 Antibodies and immunoglobulin fusion proteins having modified effector functions and uses therefor |
11/18/1998 | EP0877810A1 Methods and compositions for inhibiting hexokinase |
11/18/1998 | EP0877809A1 TOXOPLASMA GONDII ANTIGEN Tg20 |
11/18/1998 | EP0877808A1 Decorin binding protein compositions and methods of use |
11/18/1998 | EP0877807A1 Biologically active and particularly peptide molecules having a potentiating effect on growth hormone biological activity |
11/18/1998 | EP0877806A1 Nucleotide sequences that encode phosphatidylinositol-3' kinase associated proteins and uses thereof |
11/18/1998 | EP0877805A1 Tandem fluorescent protein constructs |
11/18/1998 | EP0877804A1 Inhibitors of cell-cycle progression, and uses related thereto |
11/18/1998 | EP0877803A1 Ob protein receptor and related compositions and methods |
11/18/1998 | EP0877802A1 NEUROGENIC DIFFERENTIATION (NeuroD) GENES AND PROTEINS |
11/18/1998 | EP0877796A1 Compositions and methods for mediating cell cycle progression |
11/18/1998 | EP0877761A1 Prion-free collagen and collagen-derived products and implants for multiple biomedical applications; methods of making thereof |
11/18/1998 | EP0877760A1 Mhc complexes and uses thereof |
11/18/1998 | EP0877759A1 Methods for increasing endogenous levels of corticotropin-releasing factor |
11/18/1998 | EP0877758A2 PURIFIED SR-p70 PROTEIN |
11/18/1998 | EP0877757A1 Method for evaluating and affecting male fertility |
11/18/1998 | EP0877756A1 Anti-microbial protein |
11/18/1998 | EP0877755A1 Two-component signal transduction response regulator polypeptides from staphylococcus aureus |
11/18/1998 | EP0877754A2 AMINO ACID-ENRICHED PLANT PROTEIN RESERVES, PARTICULARLY LYSINE-ENRICHED MAIZE $g(g)-ZEIN, AND PLANTS EXPRESSING SUCH PROTEINS |
11/18/1998 | EP0877752A1 Methods for screening for transdominant effector peptides and rna molecules |
11/18/1998 | EP0877632A1 Process of preparation of an autologous fibrin glue |
11/18/1998 | EP0877631A2 Conjugate for differentiating between diseased and healthy tissues |
11/18/1998 | EP0877627A1 Obesity protein analog compounds and formulations thereof |
11/18/1998 | EP0877602A1 Process for the production of powdered pulmonary surfactant preparations |